ProMIS Neurosciences Valuation
| PMN Stock | USD 12.73 0.37 2.82% |
At this time, the company appears to be undervalued. ProMIS Neurosciences holds a recent Real Value of $17.48 per share. The prevailing price of the company is $12.73. Our model determines the value of ProMIS Neurosciences from analyzing the company fundamentals such as Shares Outstanding of 2.15 M, shares owned by institutions of 50.97 %, and Return On Equity of -3.56 as well as examining its technical indicators and probability of bankruptcy. Key fundamental drivers impacting ProMIS Neurosciences' valuation include:
Price Book 2.9824 | Enterprise Value | Enterprise Value Ebitda (1.74) | Price Sales 5.2 K | Enterprise Value Revenue 3.9 K |
Undervalued
Today
Please note that ProMIS Neurosciences' price fluctuation is somewhat reliable at this time. Calculation of the real value of ProMIS Neurosciences is based on 3 months time horizon. Increasing ProMIS Neurosciences' time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since ProMIS Neurosciences is currently traded on the exchange, buyers and sellers on that exchange determine the market value of ProMIS Stock. However, ProMIS Neurosciences' intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 12.73 | Real 17.48 | Target 34.47 | Hype 12.23 | Naive 14.15 |
The intrinsic value of ProMIS Neurosciences' stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence ProMIS Neurosciences' stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of ProMIS Neurosciences helps investors to forecast how ProMIS stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of ProMIS Neurosciences more accurately as focusing exclusively on ProMIS Neurosciences' fundamentals will not take into account other important factors: Traditionally, analysts and sophisticated investors use multiple methods for valuing a cash-flow-generating entity or its stock. For example, some money managers use ProMIS Neurosciences' intrinsic value based on its ongoing forecasts of ProMIS Neurosciences' financial statements. In contrast, other private, professional wealth advisors use a multiplier approach by looking to relative value analysis against ProMIS Neurosciences' closest peers.
ProMIS Neurosciences Cash |
|
ProMIS Valuation Drivers Correlation
Many accounts on the financial statements of ProMIS Neurosciences are highly interrelated and sometimes correlated. Consequently, when conducting ProMIS's valuation analysis, one should examine all of the accounts reported to obtain a complete picture of its financial situation. We provide a unique feature to present a conventional correlation table purposely composed against different valuation-related drivers of ProMIS
Click cells to compare fundamentals
ProMIS Neurosciences Total Value Analysis
ProMIS Neurosciences is at this time expected to have company total value of 11.97 M with market capitalization of 27.4 M, debt of 2.42 M, and cash on hands of 8.95 M. Please note that company total value may be misleading and is a subject to accounting gimmicks. We encourage investors to carefully check all of the ProMIS Neurosciences fundamentals before making security assessment based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
11.97 M | 27.4 M | 2.42 M | 8.95 M |
ProMIS Neurosciences Asset Utilization
One of the ways to look at asset utilization of ProMIS is to check how much profit was generated for every dollar of assets it reports. ProMIS Neurosciences holds a negative application of assets of -0.85 pct., losing $0.008538 for each dollar of assets held by the company. Inadequate asset utilization implies the company is being less effective with each dollar of assets it holds. Put it differently, asset utilization of ProMIS Neurosciences shows how discouraging it operates for each dollar spent on its assets.ProMIS Neurosciences Profitability Analysis
Based on ProMIS Neurosciences' profitability indicators, ProMIS Neurosciences' profitability may be sliding down. It has an above-average odds of reporting lower numbers next quarter. Profitability indicators assess ProMIS Neurosciences' ability to earn profits and add value for shareholders.Net Income | First Reported 2005-06-30 | Previous Quarter -10.1 M | Current Value -11.6 M | Quarterly Volatility 2.4 M |
For ProMIS Neurosciences profitability analysis, we use financial ratios and fundamental drivers that measure the ability of ProMIS Neurosciences to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well ProMIS Neurosciences utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between ProMIS Neurosciences's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of ProMIS Neurosciences over time as well as its relative position and ranking within its peers.
ProMIS Neurosciences Earnings per Share Projection vs Actual
The next projected EPS of ProMIS Neurosciences is estimated to be -6.861075 with future projections ranging from a low of -8.1555 to a high of -3.76875. ProMIS Neurosciences' most recent 12-month trailing earnings per share (EPS TTM) is at -20.0. Please be aware that the consensus of earnings estimates for ProMIS Neurosciences is based on EPS before non-recurring items and includes expenses related to employee stock options.ProMIS Neurosciences Earnings Estimation Breakdown
The calculation of ProMIS Neurosciences' earning per share is based on the data from the past 12 consecutive months, used for reporting the company's financial figures. The next projected EPS of ProMIS Neurosciences is estimated to be -6.861075 with the future projection ranging from a low of -8.1555 to a high of -3.76875. Please be aware that this consensus of annual earnings estimates for ProMIS Neurosciences is based on EPS before non-recurring items and includes expenses related to employee stock options.Last Reported EPS
-8.16 Lowest | Expected EPS | -3.77 Highest |
ProMIS Neurosciences Earnings Projection Consensus
Suppose the current estimates of ProMIS Neurosciences' value are higher than the current market price of the ProMIS Neurosciences stock. In this case, investors may conclude that ProMIS Neurosciences is overpriced and will exhibit bullish sentiment. On the other hand, if the present value is lower than the stock price, analysts may conclude that the market undervalues the equity. These scenarios may suggest that the market is not as efficient as it should be at the estimation time, and ProMIS Neurosciences' stock will quickly adjusts to the new information provided by the consensus estimate.
| Number of Analysts | Historical Accuracy | Last Reported EPS | Estimated EPS for 31st of December 2025 | Current EPS (TTM) | |
| 4 | 55.36% | -0.24 | -6.861075 | -20.0 |
ProMIS Neurosciences Ownership Allocation
The market capitalization of ProMIS Neurosciences is $27.4 Million. Over half of ProMIS Neurosciences' outstanding shares are owned by third-party entities. These third-party entities are typically referred to as corporate investors that secure positions in a given instrument to benefit from reduced trade commissions. Note, that even with substantial debt, if the true value of the company is larger than the current market value, you may still be able to generate positive returns on investment in this company at some point.ProMIS Neurosciences Profitability Analysis
Total Income to common stockholders was 2.78 M with loss before taxes, overhead, and interest of (28.34 M).About ProMIS Neurosciences Valuation
We use absolute and relative valuation methodologies to arrive at the intrinsic value of ProMIS Neurosciences. In general, an absolute valuation paradigm, as applied to this company, attempts to find the value of ProMIS Neurosciences based exclusively on its fundamental and basic technical indicators. By analyzing ProMIS Neurosciences's financials, quarterly and monthly indicators, and their related drivers, we attempt to find the most accurate representation of ProMIS Neurosciences's intrinsic value. As compared to an absolute model, our relative valuation model uses a comparative analysis of ProMIS Neurosciences. We calculate exposure to ProMIS Neurosciences's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of ProMIS Neurosciences's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | -9.4 M | -8.9 M | |
| Pretax Profit Margin | -1.3 K | -1.4 K | |
| Operating Profit Margin | -1.2 K | -1.2 K | |
| Net Loss | -1.4 K | -1.4 K | |
| Gross Profit Margin | (646.17) | (678.48) |
ProMIS Neurosciences Current Valuation Indicators
ProMIS Neurosciences' valuation analysis is a process of estimating the intrinsic value of all assets and outstanding equities. There are different methodologies and models we use to develop the final ProMIS Neurosciences' valuation. The techniques such as discounted cash flow and fundamental indicators such as book value per share or market capitalization are well known and widely used across most financial advisers and money managers.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as ProMIS Neurosciences, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use ProMIS Neurosciences' valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes ProMIS Neurosciences' worth.When determining whether ProMIS Neurosciences offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of ProMIS Neurosciences' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Promis Neurosciences Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Promis Neurosciences Stock: Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in ProMIS Neurosciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in industry. To learn how to invest in ProMIS Stock, please use our How to Invest in ProMIS Neurosciences guide.You can also try the Competition Analyzer module to analyze and compare many basic indicators for a group of related or unrelated entities.
Will Biotechnology sector continue expanding? Could ProMIS diversify its offerings? Factors like these will boost the valuation of ProMIS Neurosciences. Anticipated expansion of ProMIS directly elevates investor willingness to pay premium valuations. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every ProMIS Neurosciences data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
ProMIS Neurosciences's market price often diverges from its book value, the accounting figure shown on ProMIS's balance sheet. Smart investors calculate ProMIS Neurosciences' intrinsic value - its true economic worth - which may differ significantly from both market price and book value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Since ProMIS Neurosciences' trading price responds to investor sentiment, macroeconomic conditions, and market psychology, it can swing far from fundamental value.
It's important to distinguish between ProMIS Neurosciences' intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding ProMIS Neurosciences should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. However, ProMIS Neurosciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.